{"podcast":{"title":"The Bio Report","slug":"the-bio-report-1092382","podcast_index_feed_id":1092382,"rss_url":"https://feed.podbean.com/thebioreport/feed.xml","website_url":"https://thebioreport.podbean.com","image_url":"https://pbcdn1.podbean.com/imglogo/image-logo/15149796/BRlogo_znb5nt.jpg","author":"Levine Media Group","episode_count":615,"summary":"The Bio Report podcast, hosted by award-winning journalist Daniel Levine, focuses on the intersection of biotechnology with business, science, and policy.","last_synced_at":null,"page_url":"https://stenobird.com/podcast/the-bio-report-1092382"},"episode":{"title":"The Year in Biotech and What’s Ahead for 2026","slug":"the-year-in-biotech-and-what-s-ahead-for-2026","published_at":"2025-12-31T08:00:00+00:00","page_url":"https://stenobird.com/podcast/the-bio-report-1092382/the-year-in-biotech-and-what-s-ahead-for-2026","show_page_url":"https://stenobird.com/podcast/the-bio-report-1092382","url":"https://thebioreport.podbean.com/e/the-year-in-biotech-and-what-s-ahead-for-2026/","audio_url":"https://mcdn.podbean.com/mf/web/i6hqp8r9rsya9g2c/BR-Adam_Feuerstein-12-31-258ycft.mp3","summary":"Biotech stocks staged a dramatic turnaround in 2025, with the XBI well outpacing the S&P 500 despite concerns over leadership changes at the U.S. Food and Drug Administration, the Trump administration’s efforts to put constraints on drug pricing, and its broader cuts to health and science agencies. A pick-up in deal-making, along with falling interest rates, helped buoy the sector with growing anticipation for continued improvement in 2026. We sat down with Adam Feuerstein, senior biotech writer for STAT, for our annual review-preview edition, the noteworthy trends in the biotech sector 2025, and what’s in store at the upcoming JPMorgan Healthcare Conference and beyond in 2026.","meta_description":"Biotech stocks staged a dramatic turnaround in 2025, with the XBI well outpacing the S&P 500 despite concerns over leadership changes at the U.S. Food…","key_points":[],"chapters":[],"topics":[],"duration_seconds":2295,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-bio-report-1092382/episodes/the-year-in-biotech-and-what-s-ahead-for-2026/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-bio-report-1092382/the-year-in-biotech-and-what-s-ahead-for-2026.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}